Skip to content

LIFECORE BIOMEDICAL, INC.: retained earnings or deficit

Retained earnings or deficit for LIFECORE BIOMEDICAL, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.

All LIFECORE BIOMEDICAL, INC. financial histories

What this measure means

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Exact concept: us-gaap:RetainedEarningsAccumulatedDeficit. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2011-05-29 to 2025-05-25. The SEC response was captured on 2026-09-20.

Selected filing history

Retained earnings or deficit in original reported units, latest-filed observation per period
Period startPeriod endValueUnitFiledSource filing
At date2025-05-25-205,240,000USD2025-08-0710-K · 0001005286-25-000108
At date2024-05-26-166,523,000USD2025-08-0710-K · 0001005286-25-000108
At date2023-05-28-178,536,000USD2024-08-2610-K · 0001005286-24-000124
At date2023-02-26-139,252,000USD2024-03-2010-K · 0001005286-24-000030
At date2022-11-27-102,745,000USD2024-03-2010-K · 0001005286-24-000030
At date2022-08-28-89,939,000USD2024-03-2010-K · 0001005286-24-000030
At date2022-05-29-78,973,000USD2024-03-2010-K · 0001005286-24-000030
At date2022-02-27-23,702,000USD2024-03-2010-K · 0001005286-24-000030
At date2021-11-28-10,116,000USD2024-03-2010-K · 0001005286-24-000030
At date2021-08-2928,355,000USD2024-03-2010-K · 0001005286-24-000030
At date2021-05-3037,742,000USD2024-03-2010-K · 0001005286-24-000030
At date2021-02-2839,025,000USD2024-03-2010-K · 0001005286-24-000030
At date2020-11-2946,003,000USD2024-03-2010-K · 0001005286-24-000030
At date2020-08-3057,626,000USD2024-03-2010-K · 0001005286-24-000030
At date2020-05-3171,245,000USD2021-07-2910-K · 0001005286-21-000043
At date2019-05-26109,710,000USD2020-08-1410-K · 0001005286-20-000004
At date2018-05-27109,299,000USD2019-08-0110-K · 0001628280-19-009791
At date2017-05-2884,470,000USD2018-08-0910-K · 0001437749-18-015135
At date2016-05-2973,457,000USD2018-03-1510-K/A · 0001437749-18-004661
At date2015-05-3185,098,000USD2016-08-0110-K · 0001437749-16-036012
At date2014-05-2571,554,000USD2015-07-3110-K · 0001437749-15-014383
At date2013-05-2652,409,000USD2014-08-0110-K · 0001437749-14-013994
At date2012-05-2729,822,000USD2013-08-0710-K · 0001437749-13-010047
At date2011-05-2917,126,000USD2012-08-0810-K · 0001437749-12-007975

Related financial histories

Inspect the source

Entity
LIFECORE BIOMEDICAL, INC. / CIK 0001005286
Captured
2026-09-20T05:11:51.367Z
SEC response SHA-256
1558a2ffe6e0c9b46b5ee698b0dbe287366a9808531f7c820d0d5517eb583dd6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001005286.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))